Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.14B | 20.00B | 19.56B | 17.97B | 14.98B | 14.12B |
Gross Profit | 5.62B | 6.41B | 4.80B | 3.99B | 3.79B | 3.35B |
EBITDA | 2.06B | 2.29B | 1.72B | 1.21B | 1.73B | 1.48B |
Net Income | 1.36B | 1.42B | 1.02B | 632.11M | 1.07B | 939.03M |
Balance Sheet | ||||||
Total Assets | 0.00 | 18.98B | 17.13B | 16.96B | 13.96B | 14.26B |
Cash, Cash Equivalents and Short-Term Investments | 715.72M | 666.26M | 613.50M | 196.42M | 360.96M | 81.44M |
Total Debt | 0.00 | 1.05B | 873.09M | 1.63B | 539.50M | 1.00B |
Total Liabilities | -11.18B | 8.14B | 7.00B | 7.78B | 5.27B | 6.06B |
Stockholders Equity | 11.18B | 10.85B | 10.14B | 9.18B | 8.70B | 8.20B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 561.68M | 1.35B | -980.91M | 675.70M | 1.07B |
Operating Cash Flow | 0.00 | 934.57M | 1.84B | -106.33M | 1.35B | 1.55B |
Investing Cash Flow | 0.00 | -377.20M | -429.91M | -864.03M | 93.09M | -1.13B |
Financing Cash Flow | 0.00 | -610.92M | -980.58M | 796.80M | -1.15B | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ₹30.79B | 8.48 | 1.55% | 23.22% | 39.31% | ||
72 Outperform | ₹23.96B | 15.99 | 0.61% | 2.61% | 24.65% | ||
69 Neutral | ₹2.30B | 6.34 | ― | 14.60% | 152.82% | ||
63 Neutral | $20.49B | 14.78 | -2.88% | 3.11% | 1.86% | -5.76% | |
62 Neutral | ₹10.47B | 30.30 | 1.30% | 13.67% | -49.85% | ||
47 Neutral | ₹27.14B | ― | ― | -11.30% | -73.75% | ||
― | ₹286.52M | ― | ― | ― | ― |
Insecticides (India) Limited has scheduled an earnings conference call on August 13, 2025, to discuss its Q1 and FY26 financial results. The call will feature key company executives, including the Managing Director, CFO, and Chief Marketing Officer, and will provide insights into the company’s financial performance and strategic direction.